Andrew E. Levitt

Overview

Mr. Levitt has a background in biotechnology research and has experience in many phases of United States and foreign intellectual property practice. As a patent associate, Mr. Levitt has experience drafting and prosecuting patent applications, and counseling clients regarding patentability, patent infringement, freedom-to-operate, and inventorship.

Experience

Mr. Levitt is experienced handling patent matters in the fields of biotechnology and chemistry, including antibodies and antibody fragments, small-molecule pharmaceuticals, laboratory equipment and methods, veterinary medicines, recombinant proteins, medical devices, methods of treatment, biochemical reagents, and nucleic acid/genetic testing, as well as synthetic materials, graphene/nanotubes, and polymers.

Education

• William & Mary, J.D., 2019
• Johns Hopkins University, Ph.D. program, Cell & Molecular Biology, 2012 – 2014
• George Washington University, B.A., Biological Sciences, 2011

Admissions

• Virginia, 2019
• Registered to practice before the U.S. Patent and Trademark Office, 2014

Courts

• U.S. Court of Appeals for Veterans Claims

Honors

Virginia Access to Justice Commission Pro Bono Service Honor Roll Member (2022, 2023, 2025)

Professional Affiliations

• Intellectual Property Owners Association (IPO)

Articles, Publications & Lectures

Adapting Bartnicki v. Vopper to a Changing Tech Landscape: Rebalancing Free Speech and Privacy in the Smartphone Age, William & Mary Bill of Rights Journal (Oct. 2018)

Amgen v. Sanofi: Seven Months In, Has Anything About Patent Enablement Changed?, IP WatchDog

Languages

• French

Practices

• Patent Preparation and Prosecution

Technologies

• Biotechnology